Sym004, a novel anti-EGFR antibody mixture augments radiation response in human lung and head and neck cancer models

被引：0
|
作者：
Huang, Shyhmin [1 ]
Armstrong, Eric A. [1 ]
Kragh, Michael [2 ]
Pedersen, Mikkel W. [2 ]
Harari, Paul M. [1 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] Symphogen AS, Lyngby, Denmark
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-2720
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2720
引用
收藏
页数：2
相关论文
共 50 条
  • [41] MM-151 Oligoclonal anti-EGFR antibody combination Treatment of colorectal cancer Treatment of non-small cell lung cancer Treatment of head and neck cancer
    Haddley, K.
    DRUGS OF THE FUTURE, 2016, 41 (12) : 725 - 730
  • [42] The anti-EGFR antibody cetuximab sensitizes human head and neck squamous cell carcinoma cells to radiation in part through inhibiting radiation-induced upregulation of HIF-1α
    Lu, Haiquan
    Liang, Ke
    Lu, Yang
    Fan, Zhen
    CANCER LETTERS, 2012, 322 (01) : 78 - 85
  • [43] Photoacoustic Molecular Imaging for the Identification of Lymph Node Metastasis in Head and Neck Cancer Using an Anti-EGFR Antibody-Dye Conjugate
    Nishio, Naoki
    van den Berg, Nynke S.
    Martin, Brock A.
    van Keulen, Stan
    Fakurnejad, Shayan
    Rosenthal, Eben L.
    Wilson, Katheryne E.
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (05) : 648 - 655
  • [44] Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, in head and neck squamous cell cancer (HNSCC)
    Bossi, P.
    Minuti, G.
    Brana, I.
    Garcia, V. Moreno
    Boni, V.
    Jamme, P.
    Call, J. A.
    Yan, C.
    Barasa, B.
    Doze, P.
    Joe, A. K.
    Laus, G.
    Daste, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S1610 - S1611
  • [45] Use of the humanized anti-EGFR monoclonal antibody h-R3 and radiotherapy in the treatment of advanced head and neck cancer patients.
    Crombet, T
    Osorio, M
    Cruz, T
    Renginfo, E
    Díaz, JR
    Del Castillo, R
    Torres, O
    Pérez, R
    Lage, A
    CLINICAL CANCER RESEARCH, 2000, 6 : 4558S - 4558S
  • [46] Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiation
    Saleh, MN
    Raisch, KP
    Stackhouse, MA
    Grizzle, WE
    Bonner, JA
    Mayo, MS
    Kim, HG
    Meredith, RF
    Wheeler, RH
    Buchsbaum, DJ
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1999, 14 (06) : 451 - 463
  • [47] MEHD7945A, dual specific antibody against EGFR and HER3, augments radiation response in head and neck squamous cell carcinoma
    Li, Chunrong
    Huang, Shyhmin
    Armstrong, Eric A.
    Sliwkowski, Mark X.
    Amler, Lukas C.
    Harari, Paul M.
    CANCER RESEARCH, 2012, 72
  • [48] Antitumor effect of IMGN289, an anti-EGFR antibody-drug conjugate (ADC), in preclinical models of head and neck squamous cell carcinomas (HNSCC)
    Kang, Hyunseok
    Thakar, Manjusha
    Sen, Rupashree
    Chung, Christine H.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] Monomethyl auristatin E-conjugated anti-EGFR antibody inhibits the growth of human EGFR-positive non-small cell lung cancer
    Zhuanglin Li
    Mingxue Wang
    Deling Yu
    Wenting Luo
    Jianmin Fang
    Changjiang Huang
    Xuejing Yao
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 61 - 72
  • [50] Monomethyl auristatin E-conjugated anti-EGFR antibody inhibits the growth of human EGFR-positive non-small cell lung cancer
    Li, Zhuanglin
    Wang, Mingxue
    Yu, Deling
    Luo, Wenting
    Fang, Jianmin
    Huang, Changjiang
    Yao, Xuejing
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (01) : 61 - 72
12345